For subjective and visual assessment, kio-predicted Ki67+ maps exhibited spatial heterogeneity, whereas those predicted by standard MRIs and other water-exchange DCE-MRI-derived pharmacokinetic metrics showed a more homogeneous distribution within the tumor. This evidence concerns the gene MKI67 and neoplasm.